{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T15:36:40Z","timestamp":1715960200483},"reference-count":47,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2013,5,14]]},"DOI":"10.4161\/hv.23970","type":"journal-article","created":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T07:18:05Z","timestamp":1362208685000},"page":"1078-1083","source":"Crossref","is-referenced-by-count":7,"title":["Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomas"],"prefix":"10.1080","volume":"9","author":[{"given":"Elena","family":"Muraro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Martorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Dolcetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,10,27]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/156800911793743664","article-title":"Cancer vaccines in phase II\/III clinical trials: state of the art and future perspectives","volume":"11","author":"Cecco","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"R2","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1200\/JCO.2010.33.3005","article-title":"Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma","volume":"29","author":"Schuster","year":"2011","journal-title":"J Clin Oncol"},{"key":"R3","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1200\/JCO.2011.35.8812","article-title":"Identifying patients with follicular lymphoma who are likely to benefit from an idiotype vaccine","volume":"29","author":"Ansell","year":"2011","journal-title":"J Clin Oncol"},{"key":"R4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood-2005-06-2517","article-title":"The paradox of response and survival in cancer therapeutics","volume":"107","author":"Huff","year":"2006","journal-title":"Blood"},{"key":"R5","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1200\/JCO.2011.38.6094","article-title":"Idiotype vaccination as consolidation therapy: time for integration into standard of care for follicular lymphoma?","volume":"29","author":"Schuster","year":"2011","journal-title":"J Clin Oncol"},{"key":"R6","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1200\/JCO.2010.28.9793","article-title":"In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I\/II study","volume":"28","author":"Brody","year":"2010","journal-title":"J Clin Oncol"},{"key":"R7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fimmu.2012.00003","article-title":"Immunotherapy for B-cell lymphoma: current status and prospective advances","volume":"3","author":"Hollander","year":"2012","journal-title":"Front Immunol"},{"key":"R8","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"key":"R9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nrc2717","article-title":"Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures","volume":"9","author":"Bendandi","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM198203043060906","article-title":"Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody","volume":"306","author":"Miller","year":"1982","journal-title":"N Engl J Med"},{"key":"R11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/13928","article-title":"Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma","volume":"5","author":"Bendandi","year":"1999","journal-title":"Nat Med"},{"key":"R12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10428190802563355","article-title":"Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma","volume":"50","author":"Timmerman","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"R13","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/jnci\/djj358","article-title":"Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma","volume":"98","author":"Inog\u00e8s","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R14","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1200\/JCO.2005.04.4289","article-title":"Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin\u2019s lymphoma resulting in durable clinical responses","volume":"24","author":"Redfern","year":"2006","journal-title":"J Clin Oncol"},{"key":"R15","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1200\/JCO.2008.19.8903","article-title":"Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma","volume":"27","author":"Freedman","year":"2009","journal-title":"J Clin Oncol"},{"key":"R16","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1200\/JCO.2010.33.3005","article-title":"Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma","volume":"29","author":"Schuster","year":"2011","journal-title":"J Clin Oncol"},{"key":"R17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djs033","article-title":"Therapeutic cancer vaccines: current status and moving forward","volume":"104","author":"Schlom","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"R18","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/eji.1830250620","article-title":"A syngeneic idiotype is immunogenic when borne by IgM but tolerogenic when joined to IgG","volume":"25","author":"Reitan","year":"1995","journal-title":"Eur J Immunol"},{"key":"R19","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.1073\/pnas.052150899","article-title":"Immunoglobulin heavy chain constant regions regulate immunity and tolerance to idiotypes of antibody variable regions","volume":"99","author":"Reitan","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2008.07143.x","article-title":"Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials","volume":"142","author":"Park","year":"2008","journal-title":"Br J Haematol"},{"key":"R21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood-2012-07-435123","article-title":"Toward an off-the-shelf vaccine for B-cell malignancies","volume":"120","author":"Gulley","year":"2012","journal-title":"Blood"},{"key":"R22","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","article-title":"Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies","volume":"119","author":"Agathangelidis","year":"2012","journal-title":"Blood"},{"key":"R23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2141.2008.07469.x","article-title":"Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study","volume":"144","author":"Bomben","year":"2009","journal-title":"Br J Haematol"},{"key":"R24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/1521-4141(200203)32:3<903::AID-IMMU903>3.0.CO;2-D","article-title":"Salivary gland B cell lymphoproliferative disorders in Sj\u00f6gren\u2019s syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins\u2019s lymphomas","volume":"32","author":"De Re","year":"2002","journal-title":"Eur J Immunol"},{"key":"R25","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1158\/1078-0432.CCR-12-0763","article-title":"IGKV3 proteins as candidate \u201coff-the-shelf\u201d vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas","volume":"18","author":"Martorelli","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R26","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1182\/blood.V95.12.3878","article-title":"Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features","volume":"95","author":"Miklos","year":"2000","journal-title":"Blood"},{"key":"R27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/modpathol.3800758","article-title":"Immunoglobulin VH gene analysis in gastric MALT lymphomas","volume":"20","author":"Sakuma","year":"2007","journal-title":"Mod Pathol"},{"key":"R28","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood-2004-01-0132","article-title":"Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia","volume":"104","author":"Tobin","year":"2004","journal-title":"Blood"},{"key":"R29","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1182\/blood-2004-03-0818","article-title":"Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins","volume":"104","author":"Widhopf","year":"2004","journal-title":"Blood"},{"key":"R30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/76243","article-title":"Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies","volume":"6","author":"Trojan","year":"2000","journal-title":"Nat Med"},{"key":"R31","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00262-005-0696-z","article-title":"Induction of anti B-cell malignance CTL response by subfamily-shared peptides derived from variable domain of immunoglobulin heavy chain","volume":"54","author":"Xiaoling","year":"2005","journal-title":"Cancer Immunol Immunother"},{"key":"R32","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1158\/1078-0432.CCR-11-0970","article-title":"Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes","volume":"17","author":"Weng","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R33","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1182\/blood-2011-09-382838","article-title":"TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas","volume":"120","author":"Weng","year":"2012","journal-title":"Blood"},{"key":"R34","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.20050068","article-title":"Among B cell non-Hodgkin\u2019s lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity","volume":"201","author":"Bende","year":"2005","journal-title":"J Exp Med"},{"key":"R35","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V97.4.1023","article-title":"V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen","volume":"97","author":"Chan","year":"2001","journal-title":"Blood"},{"key":"R36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood-2009-06-228015","article-title":"Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins","volume":"115","author":"Craig","year":"2010","journal-title":"Blood"},{"key":"R37","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V91.7.2433","article-title":"Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1\/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas","volume":"91","author":"Ivanovski","year":"1998","journal-title":"Blood"},{"key":"R38","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/eji.1830270616","article-title":"Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression","volume":"27","author":"K\u00fcppers","year":"1997","journal-title":"Eur J Immunol"},{"key":"R39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bcmd.2008.06.002","article-title":"Immunoglobulin kappa gene repertoire and somatic hypermutation patterns in follicular lymphoma","volume":"41","author":"Smilevska","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"R40","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1158\/1078-0432.CCR-10-2234","article-title":"Recommendations from the iSBTc-SITC\/FDA\/NCI Workshop on Immunotherapy Biomarkers","volume":"17","author":"Butterfield","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00262-010-0960-8","article-title":"Immunologic biomarkers as correlates of clinical response to cancer immunotherapy","volume":"60","author":"Disis","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"R42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jim.2008.10.016","article-title":"Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays","volume":"341","author":"Gnjatic","year":"2009","journal-title":"J Immunol Methods"},{"key":"R43","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1073\/pnas.0914213107","article-title":"Seromic profiling of ovarian and pancreatic cancer","volume":"107","author":"Gnjatic","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R44","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00262-009-0782-8","article-title":"Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer","volume":"59","author":"Gulley","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"R45","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nrc2761","article-title":"Mucins in cancer: function, prognosis and therapy","volume":"9","author":"Kufe","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R46","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1172\/JCI20312","article-title":"Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes","volume":"113","author":"Baskar","year":"2004","journal-title":"J Clin Invest"},{"key":"R47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbmt.2011.06.011","article-title":"Idiotype immunization following high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma","volume":"18","author":"Holman","year":"2012","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/hv.23970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T03:29:41Z","timestamp":1595474981000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/hv.23970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,14]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,10,27]]},"published-print":{"date-parts":[[2013,5,14]]}},"alternative-id":["10.4161\/hv.23970"],"URL":"https:\/\/doi.org\/10.4161\/hv.23970","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,14]]}}}